The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria

<p>Pneumococcal conjugate vaccines (PCVs) protect against invasive pneumococcal disease (IPD) among vaccinees. However, at population level, this protection is driven by indirect effects. PCVs prevent nasopharyngeal acquisition of vaccine-serotype (VT) pneumococci, reducing onward transmission...

Bibliografski detalji
Glavni autori:	Adamu, AL, Ojal, J, Abubakar, IA, Odeyemi, KA, Bello, MM, Okoromah, CAN, Karia, B, Karani, A, Akech, D, Inem, V, Scott, JAG, Adetifa, IMO
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2023

Slični predmeti

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
od: Aishatu L. Adamu, i dr.
Izdano: (2023-05-01)

Nasopharyngeal pneumococcal carriage in Nigeria: A two-site, population-based survey
od: Adetifa, I, i dr.
Izdano: (2018)

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
od: Hammitt, LL, i dr.
Izdano: (2019)

Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
od: Deirdre A. Collins, i dr.
Izdano: (2017-09-01)

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
od: Eileen M Dunne, PhD, i dr.
Izdano: (2018-12-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
od: Anna M.M. van Deursen, i dr.
Izdano: (2012-11-01)

Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine
od: Grace Mzumara, i dr.
Izdano: (2024-10-01)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.
od: Jo Southern, i dr.
Izdano: (2018-01-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
od: V. K. Tatochenko, i dr.
Izdano: (2012-03-01)

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial
od: Egere, U, i dr.
Izdano: (2012)

Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program
od: Saliha Kanık Yüksek, i dr.
Izdano: (2020-02-01)

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.
od: Uzochukwu Egere, i dr.
Izdano: (2012-01-01)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
od: Edmunds W John, i dr.
Izdano: (2010-04-01)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly.
od: Irina Kislaya, i dr.
Izdano: (2019-01-01)

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
od: Stubbs Liz, i dr.
Izdano: (2009-08-01)

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
od: Ojal, J, i dr.
Izdano: (2017)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
od: Kristiana Alexandrova Nikolova, i dr.
Izdano: (2021-10-01)

13-valent pneumococcal conjugate vaccine in Africa
od: Robert Cohen, i dr.
Izdano: (2017-03-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
od: N. L. Chernaya, i dr.
Izdano: (2012-02-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
od: James T. Peterson, i dr.
Izdano: (2019-03-01)

A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine.
od: Hamaluba, M, i dr.
Izdano: (2015)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
od: Ralf Rene Reinert, i dr.
Izdano: (2012-06-01)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan.
od: Muhammad Imran Nisar, i dr.
Izdano: (2022-01-01)

Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy.
od: Romina Camilli, i dr.
Izdano: (2013-01-01)

Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children
od: Johan Emdal Navne, i dr.
Izdano: (2017-01-01)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
od: George Gourzoulidis, i dr.
Izdano: (2023-09-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
od: Carina Valente, i dr.
Izdano: (2012-01-01)

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
od: Dr. Laura L Hammitt, MD, i dr.
Izdano: (2014-07-01)

Genetic background of Cambodian pneumococcal carriage isolates following pneumococcal conjugate vaccine 13
od: Belman, S, i dr.
Izdano: (2022)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
od: Ahmet Arvas, i dr.
Izdano: (2017-08-01)

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
od: Susanna Esposito, i dr.
Izdano: (2015-01-01)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
od: David G. McIntosh
Izdano: (2009-04-01)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
od: David G. McIntosh
Izdano: (2009-04-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
od: Sweta M Patel, i dr.
Izdano: (2022-01-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
od: N. L. Chernaya, i dr.
Izdano: (2013-01-01)

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
od: Kristiana Alexandrova Nikolova, i dr.
Izdano: (2024-02-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
od: Tatiane E. Hirose, i dr.
Izdano: (2015-03-01)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
od: Tatiane E. Hirose, i dr.
Izdano: (2015-03-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
od: Sweta M. Patel, i dr.
Izdano: (2022-01-01)

Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
od: Paul Turner, i dr.
Izdano: (2015-11-01)